Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
The New England Journal of Medicine|August 30, 2024
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, John L Berk, Julian D Gillmore, et al.
The Journal of Investigative Dermatology|September 16, 2023
Disruption of TUFT1, a Desmosome-Associated Protein, Causes Skin Fragility, Woolly Hair, and Palmoplantar KeratodermaAnnemieke J M H Verkerk, Daniela Andrei, Mathilde C S C Vermeer, et al.
Journal of the American College of Cardiology|April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial InfarctionJacob A Udell, Mark C Petrie, W Schuyler Jones, et al.
Circulation|April 6, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI TrialAdrian F Hernandez, Jacob A Udell, W Schuyler Jones, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
The New England Journal of Medicine|April 8, 2024
Empagliflozin after Acute Myocardial InfarctionJaved Butler, W Schuyler Jones, Jacob A Udell, et al.
Pageof 35